Loading...

Jazz Pharmaceuticals plc

JAZZ•NASDAQ
Healthcare
Biotechnology
$196.52
$-3.44(-1.72%)
U.S. Market opens in 49h 13m

Jazz Pharmaceuticals plc (JAZZ) Stock Overview

Explore Jazz Pharmaceuticals plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap12.1B
P/E Ratio-33.39
EPS (TTM)$-5.84
ROE-0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$168.57
3 Months$169.46
1 Year Target$152.31

JAZZ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Jazz Pharmaceuticals plc (JAZZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.58, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $152.31.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -33.39 and a market capitalization of 12.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.72%
5-Day Change
-0.81%
1-Month Change
6.22%
3-Month Change
16.48%
6-Month Change
41.86%
Year-to-Date (YTD) Change
15.60%
1-Year Change
80.33%
3-Year Change
36.02%
5-Year Change
18.66%
All-Time (Max) Change
1008.40%

Contact Information

https://www.jazzpharma.com
353 1 634 7800
Waterloo Exchange, Dublin, NaN, 4

Company Facts

2,800 Employees
IPO DateJun 1, 2007
CountryIE
Actively Trading

Frequently Asked Questions